Radiopharmaceuticals : progress and clinical perspectives /

Radiopharmaceuticals : progress and clinical perspectives /

42

Detalhes bibliográficos
Autor principal:	Fritzberg, Alan R.
Formato:
Publicado em:	Boca Raton, Fla. : CRC Pr, 1986
Assuntos:	Radiopharmaceuticals

Registros relacionados

Radiopharmaceuticals for positron emission tomography /
por: Scott, Peter J. H., et al.
Publicado em: (c201)

Radiopharmaceuticals and other compounds labelled with shortlived radionuclides /
por: Welch, Michael J.
Publicado em: (1977)

Radiopharmaceutical extravasations: a twenty year mini-review
por: Dustin R. Osborne
Publicado em: (2023-07-01)

Revolutionizing cancer treatment: The role of radiopharmaceuticals in modern cancer therapy
por: Treesa P. Varghese, et al.
Publicado em: (2024-09-01)

Radiopharmaceuticals from generator-produced radionuclides
por: International Atomic Energy Agency
Publicado em: (1971)

Adverse reactions to radiopharmaceuticals
por: María del Val Gómez-Martínez, et al.
Publicado em: (2021-05-01)

Brief Analysis of the Validation of Analytical Methods for Radiopharmaceuticals
por: Mengyi CHEN, et al.
Publicado em: (2024-12-01)

Planning a Clinical Development Programme for Radiopharmaceuticals: An Analysis of International Guidelines and Expertise
por: D. V. Goryachev, et al.
Publicado em: (2025-02-01)

Regulation of Radiopharmaceutical Products
por: V. V. Kosenko, et al.
Publicado em: (2022-12-01)

Embracing artificial intelligence design for better radiopharmaceuticals
por: Jinping Tao, et al.
Publicado em: (2024-08-01)

Pharmacokinetic Studies of Radiopharmaceuticals
por: A. S. Lunev, et al.
Publicado em: (2022-12-01)

Analytical and chromatographic technigues in radiopharmaceutical chemistry /
por: Wieland, Donald M., et al.
Publicado em: (1986)

TO THE QUESTION OF RADIATION PROTECTION ENSURING OF PASSENGERS TAKEN RADIOPHARMACEUTICALS DURING TRANSPORTATION BY RAILWAY TRANSPORT
por: N. N. Artemyeva, et al.
Publicado em: (2015-08-01)

An overview of current phase 3 radiopharmaceutical therapy clinical trials
por: Nicolas Lepareur, et al.
Publicado em: (2025-02-01)

Radiopharmaceuticals for Pancreatic Cancer: A Review of Current Approaches and Future Directions
por: Sara Calistri, et al.
Publicado em: (2024-10-01)

Possible Impurities in Radiopharmaceuticals and Corresponding Test Methods
por: G. E. Kodina, et al.
Publicado em: (2022-10-01)

The main issues of quality assurance of radiopharmaceuticals
por: G. E. Kodina, et al.
Publicado em: (2019-12-01)

Concentration of Rhenium-188 for the Radiopharmaceutical Synthesis
por: A. O. Malysheva, et al.
Publicado em: (2022-11-01)

QUALITY CONTROL OF RADIOPHARMACEUTICALS IN MEDICAL INSTITUTIONS
por: G. E. Kodina, et al.
Publicado em: (2019-01-01)

RADIOPHARMACEUTICALS BASED ON THE GLUCOSE DERIVATIVES FOR TUMOR DIAGNOSIS
por: R. V. Zeltchan, et al.
Publicado em: (2018-05-01)

Non-clinical Studies of Radiopharmaceuticals: Analysis of National and International Regulatory Practice (Review)
por: O. E. Klementyeva, et al.
Publicado em: (2024-07-01)

Nano-Radiopharmaceuticals in Colon Cancer: Current Applications, Challenges, and Future Directions
por: Ajnas Alkatheeri, et al.
Publicado em: (2025-02-01)

SYNTHESIS OF RADIOPHARMACEUTICAL WITH RHENIUM-188 AND LIPIODOL
por: G. E. Kodina, et al.
Publicado em: (2019-01-01)

Methodological Approaches to Preclinical Evaluation of General Toxicity of Therapeutic Radiopharmaceuticals
por: O. E. Klementyeva, et al.
Publicado em: (2021-12-01)

Selection and Use of Antioxidants-radioprotectors in the Composition of Therapeutic Radiopharmaceuticals (Review)
por: E. P. Pavlenko, et al.
Publicado em: (2023-12-01)

Analysis of Current Rules and Regulations for Preclinical Studies of Radiopharmaceuticals
por: A. S. Lunev, et al.
Publicado em: (2024-02-01)

Peculiarities of the Regulatory Status of Radiopharmaceuticals Manufactured in Medical Organisations
por: S. V. Shatik, et al.
Publicado em: (2022-12-01)

Non-[<sup>18</sup>F]FDG PET-Radiopharmaceuticals in Oncology
por: Antonia Dimitrakopoulou-Strauss, et al.
Publicado em: (2024-12-01)

Theoretical Study of Metal–Ligand Interactions in Lead Complexes with Radiopharmaceutical Interest
por: Attila Kovács, et al.
Publicado em: (2024-09-01)

Immunological effects of radiopharmaceutical therapy
por: Amanda G. Shea, et al.
Publicado em: (2024-04-01)

Operational guidance on hospital radiopharmacy : a safe and effective approach [electronic resource] /
por: International Atomic Energy Agency
Publicado em: (2008)

Operational guidance on hospital radiopharmacy : a safe and effective approach /
por: International Atomic Energy Agency
Publicado em: (2008)

Radiosynthesis and Preclinical Evaluation of [<sup>99m</sup>Tc]Tc-Tigecycline Radiopharmaceutical to Diagnose Bacterial Infections
por: Syeda Marab Saleem, et al.
Publicado em: (2024-09-01)

Radiopharmaceutical small-scale preparation in Europe: will we be able to harmonize the situation?
por: Estrella Moya, et al.
Publicado em: (2024-09-01)

Radiation Absorbed Dose Evaluation of [177Lu] Lu-DOTMP Radiopharmaceutical in Man Based On Biodistribution Data in Wistar Rats
por: Reza Bagheri, et al.
Publicado em: (2024-12-01)

Experience in Validation of Methods for Determination of Radiochemical Impurities in Radiopharmaceuticals
por: A. O. Malysheva, et al.
Publicado em: (2020-12-01)

Prostate-specific membrane antigen-targeting radiopharmaceuticals: a new frontier in hepatic malignancies
por: Fucen Liu, et al.
Publicado em: (2025-03-01)

Can ChatGPT help patients understand radiopharmaceutical extravasations?
por: Madeleine Alvarez
Publicado em: (2024-11-01)

[89Zr]Zr-DFO-TOC: a novel radiopharmaceutical for PET imaging of somatostatin receptor positive neuroendocrine tumors
por: Alexis M. Sanwick, et al.
Publicado em: (2024-12-01)

3D small-scale dosimetry and tumor control of 225Ac radiopharmaceuticals for prostate cancer
por: Robin Peter, et al.
Publicado em: (2024-08-01)